EMA inform Europeans about biosimilars
The European Medicines Agency (EMA) and the European Commission…
Ethical examination of clinical trials. Necessity and absence of necessity
Not all studies involving people require a prospective examination…
A new drug for the treatment of migraine may appear in Europe
The Expert Council of the European Medicines Agency recommended…
FDA has released the draft guidance on post-approval changes to the Drug Substance
On the 10th of September 2018 FDA released a new draft named…
THE FIRST INTERNATIONAL FORUM OF ONCOLOGY AND RADIOLOGY
Dear colleagues, X7 Research company will take part in the First…
The drug for the treatment of autoimmune skin disease received the status of “breakthrough therapy”
The US Food and Drug Administration (FDA) assigned the status…